Xiahong Dai
- Epidemiology
- Infectious Diseases top 10%
- Molecular Biology
- Hepatology top 10%
- Pulmonary and Respiratory Medicine
- Topics
- Liver Disease Diagnosis and Treatment (6 papers)Antifungal resistance and susceptibility (5 papers)Hepatitis B Virus Studies (5 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiahong Dai
25 papers receiving 563 citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Epidemiology 166
- Infectious Diseases 140
- Molecular Biology 117
- Hepatology 116
- Pulmonary and Respiratory Medicine 115
Countries citing papers authored by Xiahong Dai
This map shows the geographic impact of Xiahong Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiahong Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiahong Dai more than expected).
Fields of papers citing papers by Xiahong Dai
This network shows the impact of papers produced by Xiahong Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiahong Dai. The network helps show where Xiahong Dai may publish in the future.
Co-authorship network of co-authors of Xiahong Dai
This figure shows the co-authorship network connecting the top 25 collaborators of Xiahong Dai. A scholar is included among the top collaborators of Xiahong Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiahong Dai. Xiahong Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 4 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatmentbreakdown → | 195 |
| 10 | 28 | |
| 11 | 7 | |
| 12 | 10 | |
| 13 | 24 | |
| 14 | 6 | |
| 15 | 15 | |
| 16 | 43 | |
| 17 | 20 | |
| 18 | 55 | |
| 19 | 16 | |
| 20 | 18 |
About Xiahong Dai
Xiahong Dai is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 27 papers that have together received 571 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Antifungal resistance and susceptibility (5 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Hepatology (116 citations), Genetics (105 citations) and Infectious Diseases (140 citations). Xiahong Dai has collaborated with scholars based in China and United States. Frequent co-authors include Lanjuan Li, Lingling Tang, Xuegong Fan, Xiaowei Xu, Hainv Gao, Jiajia Chen, Chenxia Hu, Liang Yu, Charlie Xiang and Lü Chen. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.